Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 151–165 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5300
CHRNA1 Gene Slow‑Channel Congenital Myasthenic Syndrome Genetic Test

This genetic test identifies pathogenic variants in the CHRNA1 gene associated with slow-channel congenital myasthenic syndrome.

Whole Blood, Buccal Swab, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CHRNA1 gene", "Acetylcholine receptor alpha-1 subunit gene sequence"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the lab of any medications being taken"]
Indications
["Suspected diagnosis of slow-channel congenital myasthenic syndrome (CMS)", "Family history of CMS", "Need for precise subtyping of CMS", "Guidance for targeted therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-8 ICD-10: G70.2
Clinical summary
This genetic test identifies pathogenic variants in the CHRNA1 gene associated with slow-channel congenital myasthenic syndrome.
TEST-2294
Chromosome 11p15 Silver‑Russell Syndrome Genetic Test

This test evaluates the chromosome 11p15 region for methylation defects, copy number variations, and uniparental disomy associated with Silver-Russell syndrome.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Methylation defects", "Copy number variations", "Uniparental disomy"]
Parameters
[]
Preparation
[]
Indications
["Suspected Silver-Russell syndrome", "Differential diagnosis of growth disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94086-8 ICD-10: Q87.19
Clinical summary
This test evaluates the chromosome 11p15 region for methylation defects, copy number variations, and uniparental disomy associated with Silver-Russell syndrome.
TEST-2184
Chromosome 7q11.23 Williams-Beuren Syndrome Genetic Test

This diagnostic test evaluates for microdeletions on chromosome 7q11.23, which are characteristic of Williams-Beuren syndrome.

Whole Blood, Dried Blood Spot (FTA card), or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Microdeletions of chromosome 7q11.23", "ELN gene deletion", "Contiguous gene deletions"]
Parameters
[{"name": "Chromosome 7q11.23 Deletion", "reference_range": "Negative (No deletion detected)"}]
Preparation
["No specific fasting required", "No medication adjustments needed unless advised by physician"]
Indications
["Suspected Williams-Beuren syndrome based on clinical presentation", "Confirmation of diagnosis", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95395-7 ICD-10: Q93.82, Z13.79, Z15.09
Clinical summary
This diagnostic test evaluates for microdeletions on chromosome 7q11.23, which are characteristic of Williams-Beuren syndrome.
TEST-656
Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 1 Test

This test identifies key genetic mutations and deletions associated with Chronic Lymphocytic Leukemia (CLL). It provides crucial information for risk stratification and treatment p...

Whole Blood (EDTA Tube) 5 Days (Sample Mon, Report Sat) 750.00 AED
View
View test specifications and preparation
What it measures
["TP53 (17p deletion)", "ATM (11q deletion)", "Other clinically significant loci"]
Parameters
[]
Preparation
["Fasting is not required.", "Avoid heavy physical exertion and alcohol consumption for 24 hours prior to sampling.", "A completed Genomics Clinical Information Requisition Form (Form 20) is mandatory."]
Indications
["Diagnosis of CLL", "Prognosis assessment in CLL", "Guidance for targeted therapy selection in CLL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101467-8 ICD-10: C91.1
Clinical summary
This test identifies key genetic mutations and deletions associated with Chronic Lymphocytic Leukemia (CLL). It provides crucial information for risk stratification and treatment planning.
TEST-650
Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 2 Test

This test detects key genetic mutations and copy number variations in CLL-associated genes to guide treatment and risk stratification.

Peripheral Whole Blood (EDTA tube, lavender-top) 6–7 Days (Sample Mon, Report Sat) 750.00 AED
View
View test specifications and preparation
What it measures
["TP53 mutations", "NOTCH1 mutations", "SF3B1 mutations", "11q deletion (copy number variation)"]
Parameters
[]
Preparation
["Complete the mandatory Genomics Clinical Information Requisition Form (Form 20).", "Ensure the whole blood sample is collected in a lavender-top EDTA tube."]
Indications
["Diagnosis of CLL", "Prognosis assessment in CLL", "Guiding treatment selection in CLL", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88214-7 ICD-10: C91.1
Clinical summary
This test detects key genetic mutations and copy number variations in CLL-associated genes to guide treatment and risk stratification.
TEST-654
Chronic Lymphocytic Leukemia (CLL) Prognostic Panel Test

This test evaluates key genetic and immunophenotypic markers in blood or bone marrow to assess the prognosis and guide treatment for Chronic Lymphocytic Leukemia (CLL).

Whole Blood (EDTA) / Bone Marrow (Heparin) 7 Business Days 3,000.00 AED
View
View test specifications and preparation
What it measures
["IGHV mutation status (via PCR)", "Chromosomal abnormalities (via FISH)", "Immunophenotype (via Flow Cytometry)", "Genetic markers (via DNA Sequencing)"]
Parameters
[]
Preparation
["No fasting required.", "Collection is performed strictly within a hospital setting.", "Provide a mandatory filled Chromosome & FISH Requisition Form (Form 17)."]
Indications
["Diagnosis of Chronic Lymphocytic Leukemia (CLL)", "Risk stratification in CLL", "Guiding treatment decisions in CLL", "Determining eligibility for clinical trials"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101426-8 ICD-10: C91.1
Clinical summary
This test evaluates key genetic and immunophenotypic markers in blood or bone marrow to assess the prognosis and guide treatment for Chronic Lymphocytic Leukemia (CLL).
TEST-1718
Chronic Neutrophilic Leukemia (CNL) CSF3R & SETBP Mutation Analysis Test

This test identifies specific activating mutations in the CSF3R and SETBP1 genes, which are key diagnostic markers for Chronic Neutrophilic Leukemia (CNL).

Bone marrow aspirate or peripheral blood 7–8 business days 1,600.00 AED
View
View test specifications and preparation
What it measures
["CSF3R gene mutations (exons 14, 17)", "SETBP1 gene mutations (exon 4)"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Chronic Neutrophilic Leukemia (CNL)", "Persistent mature neutrophilia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94852-7 ICD-10: C92.3
Clinical summary
This test identifies specific activating mutations in the CSF3R and SETBP1 genes, which are key diagnostic markers for Chronic Neutrophilic Leukemia (CNL).
TEST-1712
cKIT Mutation Screening (Exons 9, 11, 13, 17) Test

This test identifies activating or resistance mutations in the KIT gene within specific exons relevant to GIST.

Tumor Tissue (FFPE block or biopsy slide) 7–8 days 1,600.00 AED
View
View test specifications and preparation
What it measures
["cKIT gene mutations", "Exons 9, 11, 13, 17"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of GIST", "Guidance for targeted therapy (e.g., imatinib)", "Prognostic assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21661-6 ICD-10: C49.9
Clinical summary
This test identifies activating or resistance mutations in the KIT gene within specific exons relevant to GIST.
TEST-5375
CLCN1 Gene Myotonia Congenita Genetic Test

This genetic test evaluates the CLCN1 gene for mutations causing myotonia congenita, a rare inherited muscle stiffness disorder.

Peripheral Whole Blood or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CLCN1 gene mutations", "Pathogenic variants (point mutations, indels, CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Mandatory pre-test genetic counselling session"]
Indications
["Suspected myotonia congenita", "Family history of myotonia congenita", "Unexplained muscle stiffness"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 47898-3 ICD-10: G71.12
Clinical summary
This genetic test evaluates the CLCN1 gene for mutations causing myotonia congenita, a rare inherited muscle stiffness disorder.
TEST-1035
Clinical Exome Sequencing (NGS) Test

This test analyzes the coding regions of over 9,300 genes to identify genetic variants associated with rare and undiagnosed diseases.

Peripheral whole blood (EDTA tube) 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Protein-coding regions of genes", "Pathogenic variants"]
Parameters
[]
Preparation
["Avoid recent blood transfusion (
Indications
["Patients with complex or undiagnosed syndromes", "Suspected rare genetic disorders", "Family history of genetic conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-5 ICD-10: Z01.818, R69
Clinical summary
This test analyzes the coding regions of over 9,300 genes to identify genetic variants associated with rare and undiagnosed diseases.
TEST-467
Clinical Exome Sequencing for Couples (Preconception Carrier Screening) Test

This test analyzes the coding regions of over 20,000 genes in both partners to identify carrier status for autosomal recessive and X-linked disorders.

Peripheral whole blood (2Γ— 8.5 mL EDTA tubes) or buccal swab per partner 14 business days 5,000.00 AED
View
View test specifications and preparation
What it measures
["Carrier status for autosomal recessive disorders", "Carrier status for X-linked disorders", "Genetic variants in coding regions of ~20,000 genes"]
Parameters
[]
Preparation
["Inform our team of current medications prior to sample collection", "Do not discontinue prescribed medication without consulting your physician"]
Indications
["Couples planning a family", "Couples with a history of genetic disorders", "Couples with consanguinity", "Couples seeking comprehensive carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81210-9 ICD-10: Z31.440, Z31.430, Z13.79
Clinical summary
This test analyzes the coding regions of over 20,000 genes in both partners to identify carrier status for autosomal recessive and X-linked disorders.
TEST-451
Clinical Exome Trio Sequencing Test

This test identifies genetic variants in the coding regions of genes from a child and both parents to diagnose rare genetic disorders.

Peripheral Whole Blood (3–5 mL per participant in EDTA tubes) or Saliva (Oragene OG-500 kit) 21 Business Days 7,500.00 AED
View
View test specifications and preparation
What it measures
["Coding regions (exomes) of genes", "Pathogenic variants", "Variants of uncertain significance (VUS)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent bone marrow or stem cell transplant"]
Indications
["Diagnosis of rare genetic disorders", "Identification of pathogenic variants", "Family history of genetic conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94041-0 ICD-10: Z13.71, Z13.79, R89.8
Clinical summary
This test identifies genetic variants in the coding regions of genes from a child and both parents to diagnose rare genetic disorders.
TEST-668
Clopidogrel CYP2C19 Genotype Test

This test evaluates genetic variations in the CYP2C19 gene that influence the metabolism and effectiveness of the antiplatelet drug clopidogrel.

Peripheral Whole Blood (EDTA Lavender Top Tube) 7–10 business days 6,000.00 AED
View
View test specifications and preparation
What it measures
["CYP2C19 gene variants (*2, *3, *17 alleles)", "Metabolizer status (Normal, Intermediate, Poor)"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Patients prescribed clopidogrel", "Patients post-coronary stent placement", "Patients post-heart attack", "Personalized antiplatelet therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 47344-8 ICD-10: Z13.89
Clinical summary
This test evaluates genetic variations in the CYP2C19 gene that influence the metabolism and effectiveness of the antiplatelet drug clopidogrel.
TEST-672
Clostridium difficile (C. difficile) PCR Detection Test

This diagnostic test evaluates stool for the presence of the tcdB gene, a marker for toxigenic Clostridium difficile.

Stool 2–3 business days (batches Monday and Thursday) 650.00 AED
View
View test specifications and preparation
What it measures
["Presence of tcdB gene (toxin B gene)", "Toxigenic Clostridium difficile"]
Parameters
[{"name": "Clinical Sensitivity", "reference_range": "β‰₯99.9%"}, {"name": "Clinical Specificity", "reference_range": "β‰₯98%"}]
Preparation
["Collect stool sample in a clean, leak-proof container", "Collect at least 5g (3g minimum) of stool", "Refrigerate sample immediately after collection"]
Indications
["Suspected Clostridioides difficile infection (CDI)", "Diarrhea following antibiotic use", "Diarrhea following hospitalization", "Evaluation of recurrent CDI", "Diagnosis in patients with severe gastrointestinal symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34715-3 ICD-10: A04.7
Clinical summary
This diagnostic test evaluates stool for the presence of the tcdB gene, a marker for toxigenic Clostridium difficile.
TEST-3453
CNGA3 Gene Achromatopsia TypeΒ 2 Genetic Test

This test identifies pathogenic variants within the CNGA3 gene associated with autosomal recessive achromatopsia type 2.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CNGA3 gene"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Diagnosis of suspected achromatopsia type 2", "Carrier screening for individuals with family history", "Genetic counseling for reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98796-9 ICD-10: H53.51
Clinical summary
This test identifies pathogenic variants within the CNGA3 gene associated with autosomal recessive achromatopsia type 2.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area